[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100394880":3},{"organization":4,"armGroups":7,"interventions":43,"overallOfficials":56,"centralContacts":57,"locations":67,"responsibleParty":419,"collaborators":56,"id":421,"slug":422,"hasResults":423,"nctId":424,"briefTitle":425,"officialTitle":426,"acronym":56,"eligibilityCriteria":427,"healthyVolunteers":423,"sex":428,"minAge":429,"maxAge":56,"enrollmentInfo":430,"targetDuration":56,"studyType":433,"phases":434,"briefSummary":437,"conditions":438,"keywords":56,"overallStatus":94,"whyStopped":56,"lastUpdateSubmitDate":443,"lastUpdatePostDateStruct":444,"startDateStruct":447,"completionDateStruct":449,"leadSponsor":451,"locationsCount":452},{"fullName":5,"class":6},"Bold Therapeutics, Inc.","INDUSTRY",[8,14,17,20,23,26,29,35,39],{"label":9,"type":10,"description":11,"interventionNames":12},"Part B - Dose Expansion - 1L Gastric Cancer (ARM I)","EXPERIMENTAL","Arm closed to enrollment.",[13],"Drug: BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI)",{"label":15,"type":10,"description":11,"interventionNames":16},"Part B - Dose Expansion - 2L Gastric Cancer (ARM II)",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Part B - Dose Expansion - 2L Pancreatic Cancer (ARM III)",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"Part B - Dose Expansion - 2L Colorectal Cancer (ARM IV)",[13],{"label":24,"type":10,"description":11,"interventionNames":25},"Part B - Dose Expansion - 2L Cholangiocarcinoma (ARM V)",[13],{"label":27,"type":10,"description":11,"interventionNames":28},"Part B - Dose Expansion - 3L Colorectal Cancer (ARM VI)",[13],{"label":30,"type":31,"description":32,"interventionNames":33},"Part B - Dose Expansion - 2L Colorectal Cancer (ARM VIIA)","ACTIVE_COMPARATOR","Arm open to enrollment. 500 mg\u002Fm2 BOLD-100 + SOC FOLFOX",[34],"Drug: BOLD-100 +\u002F- FOLFOX Chemotherapy (Arm VII)",{"label":36,"type":31,"description":37,"interventionNames":38},"Part B - Dose Expansion - 2L Colorectal Cancer (ARM VIIB)","Arm open to enrollment. 625 mg\u002Fm2 BOLD-100 + FOLFOX",[34],{"label":40,"type":31,"description":41,"interventionNames":42},"Part B - Dose Expansion - 2L Colorectal Cancer (ARM VIIC)","Arm open to enrollment. FOLFOX alone.",[34],[44,51],{"type":45,"name":46,"description":47,"armGroupLabels":48,"otherNames":49},"DRUG","BOLD-100 +\u002F- FOLFOX Chemotherapy (Arm VII)","Arm VIIA: 500 mg\u002Fm2 BOLD-100 combined with FOLFOX; Arm VIIB: 625 mg\u002Fm2 BOLD-100 combined with FOLFOX; Arm VIIC: FOLFOX alone",[30,36,40],[50],"BOLD-100 +\u002F- Folinic acid (leucovorin), Fluorouracil (5-FU), and Oxaliplatin.",{"type":45,"name":52,"description":53,"armGroupLabels":54,"otherNames":55},"BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI)","BOLD-100 at 625 mg\u002Fm2 combined with FOLFOX Chemotherapy",[9,24,21,15,18,27],[50],null,[58,63],{"name":59,"role":60,"phone":61,"phoneExt":56,"email":62},"Michelle Jones","CONTACT","604-262-9899","clinical@bold-therapeutics.com",{"name":64,"role":60,"phone":65,"phoneExt":56,"email":66},"Jim Pankovich","604-262-9934","jp@bold-therapeutics.com",[68,82,92,112,130,148,165,182,194,211,225,243,257,270,287,301,315,332,349,359,369,378,394,408],{"facility":69,"status":70,"city":71,"state":72,"zip":73,"country":74,"countryCode":75,"cosmosGeoPoint":76,"geoPoint":81,"contacts":56},"University of California, Los Angeles","COMPLETED","Santa Monica","California","90095","United States","US",{"type":77,"coordinates":78},"Point",[79,80],-118.49138,34.01949,{"lat":80,"lon":79},{"facility":83,"status":70,"city":84,"state":85,"zip":86,"country":74,"countryCode":75,"cosmosGeoPoint":87,"geoPoint":91,"contacts":56},"Moffitt Cancer Center","Tampa","Florida","33612",{"type":77,"coordinates":88},[89,90],-82.45843,27.94752,{"lat":90,"lon":89},{"facility":93,"status":94,"city":95,"state":96,"zip":56,"country":97,"countryCode":98,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"Cross Cancer Institue","RECRUITING","Edmonton","Alberta","Canada","CA",{"type":77,"coordinates":100},[101,102],-113.46871,53.55014,{"lat":102,"lon":101},[105,109],{"name":106,"role":60,"phone":107,"phoneExt":56,"email":108},"Carly Mack","780-432-8823","Carly.Mack@ahs.ca",{"name":110,"role":60,"phone":56,"phoneExt":56,"email":111},"Lindzie Sinclair","Lindzie.Sinclair@ahs.ca",{"facility":113,"status":94,"city":114,"state":115,"zip":56,"country":97,"countryCode":98,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Juravinski Cancer Centre","Hamilton","Ontario",{"type":77,"coordinates":117},[118,119],-79.84963,43.25011,{"lat":119,"lon":118},[122,127],{"name":123,"role":60,"phone":124,"phoneExt":125,"email":126},"Carrie Ferguson","905-521-2100","64416","Fergusonca@hhsc.ca",{"name":128,"role":60,"phone":56,"phoneExt":56,"email":129},"Stephanie Skeldon","Skeldon@hhsc.ca",{"facility":131,"status":94,"city":132,"state":115,"zip":56,"country":97,"countryCode":98,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"The Ottawa Hospital Cancer Centre","Ottawa",{"type":77,"coordinates":134},[135,136],-75.69812,45.41117,{"lat":136,"lon":135},[139,144],{"name":140,"role":60,"phone":141,"phoneExt":142,"email":143},"Saara Ali","613-737-7700","70211","saali@ohri.ca",{"name":145,"role":60,"phone":141,"phoneExt":146,"email":147},"Rose Leclerc","70303","roleclerc@ohri.ca",{"facility":149,"status":94,"city":150,"state":115,"zip":56,"country":97,"countryCode":98,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"Princess Margaret Cancer Centre","Toronto",{"type":77,"coordinates":152},[153,154],-79.39864,43.70643,{"lat":154,"lon":153},[157,160],{"name":158,"role":60,"phone":56,"phoneExt":56,"email":159},"Mopina Shrikumar","Mopina.Shrikumar@uhn.ca",{"name":161,"role":60,"phone":162,"phoneExt":163,"email":164},"Cynthia Bocaya","416-946-4501","4713","Cynthia.Bocaya@uhn.ca",{"facility":166,"status":94,"city":167,"state":168,"zip":56,"country":97,"countryCode":98,"cosmosGeoPoint":169,"geoPoint":173,"contacts":174},"Jewish General Hospital","Montreal","Quebec",{"type":77,"coordinates":170},[171,172],-73.58781,45.50884,{"lat":172,"lon":171},[175,178],{"name":176,"role":60,"phone":56,"phoneExt":56,"email":177},"Yacine Tchemmoun","Yacine.Tchemmoun.ccomtl@ssss.gouv.qc.ca",{"name":179,"role":60,"phone":180,"phoneExt":56,"email":181},"Ewa Forczek","514-340-8222","Ewa.Forczek.ccomtl@ssss.gouv.qc.ca",{"facility":183,"status":94,"city":167,"state":168,"zip":56,"country":97,"countryCode":98,"cosmosGeoPoint":184,"geoPoint":186,"contacts":187},"McGill University Health Centre Glen Site",{"type":77,"coordinates":185},[171,172],{"lat":172,"lon":171},[188,191],{"name":189,"role":60,"phone":56,"phoneExt":56,"email":190},"Wafaa Chebaro","Wafaa.Chebaro@muhc.mcgill.ca",{"name":192,"role":60,"phone":56,"phoneExt":56,"email":193},"Zak Dembele","Aboudrazako.Dembele@muhc.mcgill.ca",{"facility":195,"status":94,"city":196,"state":56,"zip":56,"country":197,"countryCode":198,"cosmosGeoPoint":199,"geoPoint":203,"contacts":204},"Universitatsklinikum Bonn","Bonn","Germany","DE",{"type":77,"coordinates":200},[201,202],7.09549,50.73438,{"lat":202,"lon":201},[205,209],{"name":206,"role":60,"phone":207,"phoneExt":56,"email":208},"Maria Gonzalez-Carmona","+49 228 287 17014","Maria.Gonzalez-Carmona@ukbonn.de",{"name":206,"role":210,"phone":56,"phoneExt":56,"email":56},"PRINCIPAL_INVESTIGATOR",{"facility":212,"status":94,"city":213,"state":56,"zip":56,"country":197,"countryCode":198,"cosmosGeoPoint":214,"geoPoint":218,"contacts":219},"University Hospital of Ulm","Ulm",{"type":77,"coordinates":215},[216,217],9.99155,48.39841,{"lat":217,"lon":216},[220,224],{"name":221,"role":60,"phone":222,"phoneExt":56,"email":223},"Thomas Seufferlein","+49 731 500 44501","thomas.seufferlein@uniklinik-ulm.de",{"name":221,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":226,"status":94,"city":227,"state":56,"zip":56,"country":228,"countryCode":229,"cosmosGeoPoint":230,"geoPoint":234,"contacts":235},"Mater Miserecordiae University Hospital","Dublin","Ireland","IE",{"type":77,"coordinates":231},[232,233],-6.24889,53.33306,{"lat":233,"lon":232},[236,239,242],{"name":237,"role":60,"phone":56,"phoneExt":56,"email":238},"Austin Duffy","austin.duffy@startdublin.com",{"name":240,"role":60,"phone":56,"phoneExt":56,"email":241},"Niamh Ni Obain","Niamh.obain@startdublin.com",{"name":237,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":244,"status":94,"city":227,"state":56,"zip":56,"country":228,"countryCode":229,"cosmosGeoPoint":245,"geoPoint":247,"contacts":248},"St. James Hospital",{"type":77,"coordinates":246},[232,233],{"lat":233,"lon":232},[249,253,256],{"name":250,"role":60,"phone":251,"phoneExt":56,"email":252},"Emily Harrold, Dr","+353 1 410 3000","eharrold@stjames.ie",{"name":254,"role":60,"phone":56,"phoneExt":56,"email":255},"Trisha Lima","TLima@stjames.ie",{"name":250,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":258,"status":94,"city":227,"state":56,"zip":56,"country":228,"countryCode":229,"cosmosGeoPoint":259,"geoPoint":261,"contacts":262},"St. Vincent's University Hospital",{"type":77,"coordinates":260},[232,233],{"lat":233,"lon":232},[263,266,269],{"name":264,"role":60,"phone":56,"phoneExt":56,"email":265},"Fergus Keane","ferguskeane@svhg.ie",{"name":267,"role":60,"phone":56,"phoneExt":56,"email":268},"Fausta Barizaite","fausta.barizaite@ccrt.ie",{"name":264,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":271,"status":272,"city":273,"state":56,"zip":56,"country":274,"countryCode":275,"cosmosGeoPoint":276,"geoPoint":280,"contacts":281},"Fondazione IRCCS \"Istituto Nazionale dei Tumori","NOT_YET_RECRUITING","Milan","Italy","IT",{"type":77,"coordinates":277},[278,279],9.18951,45.46427,{"lat":279,"lon":278},[282,286],{"name":283,"role":60,"phone":284,"phoneExt":56,"email":285},"Federica Morano","390223903807","Federica.Morano@istitutotumori.mi.it",{"name":283,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":288,"status":272,"city":289,"state":56,"zip":56,"country":274,"countryCode":275,"cosmosGeoPoint":290,"geoPoint":294,"contacts":295},"AOU L. Vanvitelli","Naples",{"type":77,"coordinates":291},[292,293],14.26811,40.85216,{"lat":293,"lon":292},[296,300],{"name":297,"role":60,"phone":298,"phoneExt":56,"email":299},"Stefania Napolitano","393287269612","stefania.napolitano@unicampania.it",{"name":297,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":302,"status":272,"city":303,"state":56,"zip":56,"country":274,"countryCode":275,"cosmosGeoPoint":304,"geoPoint":308,"contacts":309},"Azienda Ospedaliero Universitaria Pisana","Pisa",{"type":77,"coordinates":305},[306,307],10.4036,43.70853,{"lat":307,"lon":306},[310,314],{"name":311,"role":60,"phone":312,"phoneExt":56,"email":313},"Chiara Cremolini","39050993173","chiaracremolini@gmail.com",{"name":311,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":316,"status":94,"city":317,"state":56,"zip":56,"country":318,"countryCode":56,"cosmosGeoPoint":319,"geoPoint":323,"contacts":324},"National Cancer Center","Goyang","South Korea",{"type":77,"coordinates":320},[321,322],127.19731,36.21689,{"lat":322,"lon":321},[325,328],{"name":326,"role":60,"phone":56,"phoneExt":56,"email":327},"Min Ji Kim","12991@ncc.re.kr",{"name":329,"role":60,"phone":330,"phoneExt":56,"email":331},"Yeon Hee Lee","010-7109-6752","Yunsoo86@ncc.re.kr",{"facility":333,"status":94,"city":334,"state":56,"zip":56,"country":318,"countryCode":56,"cosmosGeoPoint":335,"geoPoint":339,"contacts":340},"Kangbuk Samsung Hospital","Seoul",{"type":77,"coordinates":336},[337,338],126.9784,37.566,{"lat":338,"lon":337},[341,345],{"name":342,"role":60,"phone":343,"phoneExt":56,"email":344},"Min Ju Cho","+82 2 2001 1526","m0360.Cho@samsung.com",{"name":346,"role":60,"phone":347,"phoneExt":56,"email":348},"Ji Won Lee","+82 2 2001 1578","Jiwon.Lee@samsung.com",{"facility":350,"status":94,"city":334,"state":56,"zip":56,"country":318,"countryCode":56,"cosmosGeoPoint":351,"geoPoint":353,"contacts":354},"Samsung Medical Center",{"type":77,"coordinates":352},[337,338],{"lat":338,"lon":337},[355],{"name":356,"role":60,"phone":357,"phoneExt":56,"email":358},"Yeong Seo","+82 2 2148 9848","yeonog.seo@sbri.co.kr",{"facility":360,"status":94,"city":334,"state":56,"zip":56,"country":318,"countryCode":56,"cosmosGeoPoint":361,"geoPoint":363,"contacts":364},"Seoul National University Hospital",{"type":77,"coordinates":362},[337,338],{"lat":338,"lon":337},[365],{"name":366,"role":60,"phone":367,"phoneExt":56,"email":368},"Hyang mi Kang","(+)82 2 6072 5172","49001@snuh.org",{"facility":370,"status":94,"city":334,"state":56,"zip":56,"country":318,"countryCode":56,"cosmosGeoPoint":371,"geoPoint":373,"contacts":374},"Severance Hospital - Yonsei University",{"type":77,"coordinates":372},[337,338],{"lat":338,"lon":337},[375],{"name":376,"role":60,"phone":56,"phoneExt":56,"email":377},"Anna Yeun","annay@yuhs.ac",{"facility":379,"status":272,"city":380,"state":56,"zip":56,"country":381,"countryCode":382,"cosmosGeoPoint":383,"geoPoint":387,"contacts":388},"Vall Hebron Institute of Oncology (VHIO)","Barcelona","Spain","ES",{"type":77,"coordinates":384},[385,386],2.15899,41.38879,{"lat":386,"lon":385},[389,393],{"name":390,"role":60,"phone":391,"phoneExt":56,"email":392},"Elena Elez","34 932746000","meelez@vhio.net",{"name":390,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":395,"status":272,"city":396,"state":56,"zip":56,"country":381,"countryCode":382,"cosmosGeoPoint":397,"geoPoint":401,"contacts":402},"Early Phase Unit FJD START Madrid","Madrid",{"type":77,"coordinates":398},[399,400],-3.70256,40.4165,{"lat":400,"lon":399},[403,407],{"name":404,"role":60,"phone":405,"phoneExt":56,"email":406},"Manuel Pedregal Trujillo","34 660559027","manuel.pedregal@startmadrid.com",{"name":404,"role":210,"phone":56,"phoneExt":56,"email":56},{"facility":409,"status":272,"city":396,"state":56,"zip":56,"country":381,"countryCode":382,"cosmosGeoPoint":410,"geoPoint":412,"contacts":413},"Hospital 12 de Octubre",{"type":77,"coordinates":411},[399,400],{"lat":400,"lon":399},[414,418],{"name":415,"role":60,"phone":416,"phoneExt":56,"email":417},"Jorge Barriuso","34 913908926","jorge.barriuso.imas12@h12o.es",{"name":415,"role":210,"phone":56,"phoneExt":56,"email":56},{"type":420,"investigatorFullName":56,"investigatorTitle":56,"investigatorAffiliation":56,"oldNameTitle":56,"oldOrganization":56},"SPONSOR","100394880","phase-1-bold-100-in-combination-with-folfox-for-the-treatment-of-advanced-solid-tumours-100394880",false,"NCT04421820","BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours","A Phase 1b\u002F2a Dose Escalation Study of BOLD-100 in Combination With FOLFOX Chemotherapy in Patients With Advanced Solid Tumours","Inclusion Criteria:\n\n1. Be 18 years or older.\n2. Be male or non-pregnant females who agree to comply with applicable contraceptive requirements of the protocol.\n3. Histologically and\u002For cytologically confirmed gastrointestinal tumours that are metastatic or unresectable. (ARM VII): Patients must have received only 1 prior line of therapy in the metastatic setting.\n4. Have measurable disease according to RECIST v1.1.\n5. Have an anticipated survival of at least 16 weeks.\n6. Be ambulatory, with an ECOG performance score of 0 or 1.\n7. Have adequate organ function.\n8. Be on stable doses of any drugs that may affect hepatic drug metabolism or renal drug excretion.\n9. Be fully informed about their illness and the investigational nature of the study protocol, and sign a REB-approved Informed Consent Form (ICF).\n10. (ARM VII): BRAF wild-type tumour status.\n\nExclusion Criteria:\n\n1. Neuropathy \\> grade 2\n2. Previous intolerance to or significant reaction secondary to fluorouracil or oxaliplatin.\n3. Cerebrovascular accident within the past 6 months before the start of treatment.\n4. History or presence of central nervous system (CNS) metastasis or leptomeningeal tumours.\n5. Any serious medical conditions that might be aggravated by treatment or limit compliance.\n6. Any history of serious cardiac illness.\n7. Hemoptysis, cerebral, or clinically significant gastrointestinal hemorrhage in the past 6 months before the start of treatment.\n8. Any other known malignancy within 3 years before the start of treatment.\n9. Active gastrointestinal tract disease with malabsorption syndrome.\n10. Non-healing wound, fracture, or ulcer, or presence of symptomatic peripheral vascular disease.\n11. Treatment with radiation therapy or surgery within 4 weeks prior to starting treatment.\n12. Recent history of weight loss \\> 10% of current body weight in past 3 months before the start of treatment.\n13. HIV-positive subjects on combination anti-retroviral therapy due to the potential for PK interactions with the study agent.\n14. Concurrent use of another investigational therapy or anti-cancer therapy within 4 weeks before the start of treatment.\n15. Currently breastfeeding\n16. Dihydropyrimidine Dehydrogenase (DPD) deficiency\n17. Current or prior treatment with potent inhibitors of Dihydropyrimidine Dehydrogenase (DPD)\n18. (ARM VII): Prior exposure to BOLD-100\n19. (ARM VII): Subjects with microsatellite-high (MSI-H) Tumours\n20. (ARM VII): Concurrent monoclonal antibody therapy for mCRC (anti-EGFR, anti-VEGF or anti-HER2)","ALL","18 Years",{"count":431,"type":432},220,"ESTIMATED","INTERVENTIONAL",[435,436],"PHASE1","PHASE2","BOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially decrease the expression of GRP78 in tumour cells and ER stressed cells when compared to normal cells. BOLD-100 will be combined with cytotoxic FOLFOX chemotherapy in this study, with a dose escalation cohort to ensure tolerability and safety, followed by a cohort expansion phase.",[439,440,441,442],"Colorectal Cancer","Pancreatic Cancer","Gastric Cancers","Cholangiocarcinoma","2026-05-15",{"date":445,"type":446},"2026-05-18","ACTUAL",{"date":448,"type":446},"2020-08-28",{"date":450,"type":432},"2026-09-01",{"name":5,"class":6},24]